Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry's ...

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press ...

The global small molecule API market size was valued at USD 206.9 billion in 2025 and is predicted to hit around USD 374.03 billion by 2035, rising at a 6.1% CAGR, a study published by Towards ...

- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of ...

Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...